Raymond James Financial Services Advisors, Inc. Cybin Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $66.3 Billion
- Q1 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Cybin Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 96,600 shares of CYBN stock, worth $25,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,600Holding current value
$25,116% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CYBN
# of Institutions
109Shares Held
243MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$15.1 Million0.79% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$10.4 Million1.53% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$9.07 Million0.55% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$6.65 Million1.64% of portfolio
-
Octagon Capital Advisors LP New York, NY18.6MShares$4.84 Million1.19% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $43.2M
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...